Protein glycation - Between tissue aging and protection

Experimental Gerontology

Volumn 68, Issue , 2015, Pages 71-75

  Simm, Andreas ^a   Müller, Beatrice ^a   Nass, Norbert ^a   Hofmann, Britt ^a   Bushnaq, Hasan ^a   Silber, Rolf Edgar ^a   Bartling, Babett ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Advanced glycation endproducts; Aging; Cardiovascular diseases; Glycation; Ischemia reperfusion injury; Tumor formation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; REACTIVE OXYGEN METABOLITE;

AGING; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; CARCINOGENESIS; CELL DAMAGE; DISEASE ASSOCIATION; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; LUNG CANCER; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REPERFUSION INJURY; TISSUE AGING; TISSUE PROTECTION; ADULT; AGED; ANIMAL; DISEASE MODEL; FOOD; GLYCOSYLATION; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MOUSE; PHYSIOLOGY;

ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGED; AGING; ANIMALS; DISEASE MODELS, ANIMAL; FOOD; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LUNG NEOPLASMS; MICE; MIDDLE AGED; REPERFUSION INJURY;

EID: 84941314136     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.12.013     Document Type: Article

References (57)

1. Abe R., Shimizu T., Sugawara H., Watanabe H., Nakamura H., Choei H., Sasaki N., Yamagishi S., Takeuchi M., Shimizu H. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. J. Invest. Dermatol. 2004, 122:461-467.
2. Ahmed N., Thornalley P.J. Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo. Ann. N. Y. Acad. Sci. 2005, 1043:260-266.
3. An X.F., Zhou L., Jiang P.J., Yan M., Huang Y.J., Zhang S.N., Niu Y.F., Ten S.C., Yu J.Y. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor. Mol. Cell. Biochem. 2011, 354:47-55.
4. Bartling B., Friedrich I., Silber R.E., Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann. Thorac. Surg. 2003, 76:105-111.
5. Bartling B., Hofmann H.S., Weigle B., Silber R.E., Simm A. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 2005, 26:293-301.
6. Bartling B., Desole M., Rohrbach S., Silber R.E., Simm A. Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. FASEB J. 2009, 23:1510-1520.
7. Bartling B., Hofmann H.S., Sohst A., Hatzky Y., Somoza V., Silber R.E., Simm A. Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma. Mol. Med. 2011, 17:980-989.
8. Bartling B., Simm A., Sohst A., Silber R.E., Hofmann H.S. Effect of diabetes mellitus on the outcome of patients with resected non-small cell lung carcinoma. Gerontology 2011, 57:497-501.
9. Beisswenger P.J., Howell S.K., Russell G.B., Miller M.E., Rich S.S., Mauer M. Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care 2013, 36:3234-3239.
10. Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword?. J. Clin. Invest. 1985, 76:1713-1719.
11. Brownlee M. The pathological implications of protein glycation. Clin. Invest. Med. 1995, 18:275-281.
12. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 1985, 34:938-941.
13. Bulteau A.L., Verbeke P., Petropoulos I., Chaffotte A.F., Friguet B. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20S proteasome degradation in vitro. J. Biol. Chem. 2001, 276:45662-45668.
14. Bunn H.F., Higgins P.J. Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981, 213:222-224.
15. Cai W., He J.C., Zhu L., Chen X., Wallenstein S., Striker G.E., Vlassara H. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am. J. Pathol. 2007, 170:1893-1902.
16. Cai W., He J.C., Zhu L., Chen X., Zheng F., Striker G.E., Vlassara H. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am. J. Pathol. 2008, 173:327-336.
17. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., O'Keefe J.H., Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81:341-354.
18. Daoud S., Schinzel R., Neumann A., Loske C., Fraccarollo D., Diez C., Simm A. Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts. Mol. Med. 2001, 7:543-551.
19. Dubois-Rande J.L., Artigou J.Y., Darmon J.Y., Habbal R., Manuel C., Tayarani I., Castaigne A., Grosgogeat Y. Oxidative stress in patients with unstable angina. Eur. Heart J. 1994, 15:179-183.
20. Franks F. Physical chemistry of small carbohydrates-equilibrium solution properties. Pure Appl. Chem. 1987, 59:1189-1202.
21. Friedrich I., Simm A., Kotting J., Tholen F., Fischer B., Silber R.E. Cardiac surgery in the elderly patient. Dtsch. Arztebl. Int. 2009, 106:416-422.
22. Furber J.D. Extracellular glycation crosslinks: prospects for removal. Rejuvenation Res. 2006, 9:274-278.
23. Gebhardt C., Riehl A., Durchdewald M., Nemeth J., Furstenberger G., Muller-Decker K., Enk A., Arnold B., Bierhaus A., Nawroth P.P., Hess J., Angel P. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 2008, 205:275-285.
24. Hattori Y., Suzuki M., Hattori S., Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 2002, 39:22-28.
25. Hunter S.J., Boyd A.C., O'Harte F.P., McKillop A.M., Wiggam M.I., Mooney M.H., McCluskey J.T., Lindsay J.R., Ennis C.N., Gamble R., Sheridan B., Barnett C.R., McNulty H., Bell P.M., Flatt P.R. Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Diabetes 2003, 52:492-498.
26. Kirkwood T.B. A systematic look at an old problem. Nature 2008, 451:644-647.
27. Kloner R.A., Shook T., Przyklenk K., Davis V.G., Junio L., Matthews R.V., Burstein S., Gibson M., Poole W.K., Cannon C.P., et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?. Circulation 1995, 91:37-45.
28. Lo T.W., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 1994, 269:32299-32305.
29. Maillard L.C. Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C. R. Acad. Sci. Ser. 1912, 154:66-68.
30. Meerwaldt R., Lutgers H.L., Links T.P., Graaff R., Baynes J.W., Gans R.O., Smit A.J. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007, 30:107-112.
31. Moore T.C., Moore J.E., Kaji Y., Frizzell N., Usui T., Poulaki V., Campbell I.L., Stitt A.W., Gardiner T.A., Archer D.B., Adamis A.P. The role of advanced glycation end products in retinal microvascular leukostasis. Invest. Ophthalmol. Vis. Sci. 2003, 44:4457-4464.
32. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
33. Nass N., Bartling B., Navarrete Santos A., Scheubel R.J., Borgermann J., Silber R.E., Simm A. Advanced glycation end products, diabetes and ageing. Z. Gerontol. Geriatr. 2007, 40:349-356.
34. Nass N., Vogel K., Hofmann B., Presek P., Silber R.E., Simm A. Glycation of PDGF results in decreased biological activity. Int. J. Biochem. Cell Biol. 2010, 42:749-754.
35. Oeppen J., Vaupel J.W. Demography. Broken limits to life expectancy. Science 2002, 296:1029-1031.
36. Ott C., Jacobs K., Haucke E., Navarrete Santos A., Grune T., Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014, 2:411-429.
37. Padayatti P.S., Jiang C., Glomb M.A., Uchida K., Nagaraj R.H. High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr. Eye Res. 2001, 23:106-115.
38. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J., Chow W.S., Stern D., Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 1998, 4:1025-1031.
39. Rosenfeldt F.L., Pepe S., Linnane A., Nagley P., Rowland M., Ou R., Marasco S., Lyon W. The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology 2002, 3:37-40.
40. Ruhs S., Nass N., Bartling B., Bromme H.J., Leuner B., Somoza V., Friess U., Silber R.E., Simm A. Preconditioning with Maillard reaction products improves antioxidant defence leading to increased stress tolerance in cardiac cells. Exp. Gerontol. 2010, 45:752-762.
41. Salahuddin P., Rabbani G., Khan R.H. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. Cell. Mol. Biol. Lett. 2014, 19:407-437.
42. Sato Y., Kondo T., Ohshima T. Estimation of age of human cadavers by immunohistochemical assessment of advanced glycation end products in the hippocampus. Histopathology 2001, 38:217-220.
43. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 1997, 99:457-468.
44. Sell D.R., Kleinman N.R., Monnier V.M. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J. 2000, 14:145-156.
45. Semchyshyn H.M., Lozinska L.M., Miedzobrodzki J., Lushchak V.I. Fructose and glucose differentially affect aging and carbonyl/oxidative stress parameters in Saccharomyces cerevisiae cells. Carbohydr. Res. 2011, 346:933-938.
46. Simm A. Protein glycation during aging and in cardiovascular disease. J. Proteomics 2013, 92:248-259.
47. Simm A., Friedrich I., Scheubel R.J., Gursinsky T., Silber R.E., Bartling B. Age dependency of the cariporide-mediated cardio-protection after simulated ischemia in isolated human atrial heart muscles. Exp. Gerontol. 2008, 43:691-699.
48. Somoza V., Wenzel E., Lindenmeier M., Grothe D., Erbersdobler H.F., Hofmann T. Influence of feeding malt, bread crust, and a pronylated protein on the activity of chemopreventive enzymes and antioxidative defense parameters in vivo. J. Agric. Food Chem. 2005, 53:8176-8182.
49. Stitt A.W. AGEs and diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2010, 51:4867-4874.
50. Stolzing A., Widmer R., Jung T., Voss P., Grune T. Degradation of glycated bovine serum albumin in microglial cells. Free Radic. Biol. Med. 2006, 40:1017-1027.
51. Thornalley P.J. Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation endproducts in tissue damage. Novartis Found. Symp. 2007, 285:229-243. (discussion 243-6).
52. Uchiki T., Weikel K.A., Jiao W., Shang F., Caceres A., Pawlak D., Handa J.T., Brownlee M., Nagaraj R., Taylor A. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell 2012, 11:1-13.
53. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma J.W., Lafeber F.P., Tekoppele J.M. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 2000, 350(Pt 2):381-387.
54. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., Mizrahi J., Schalkwijk C.G., Thorpe S.R., Baynes J.W., Bijlsma J.W., Lafeber F.P., TeKoppele J.M. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002, 46:114-123.
55. Westwood M.E., Argirov O.K., Abordo E.A., Thornalley P.J. Methylglyoxal-modified arginine residues-a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta 1997, 1356:84-94.
56. Willemsen S., Hartog J.W., Heiner-Fokkema M.R., van Veldhuisen D.J., Voors A.A. Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Fail. Rev. 2012, 17:221-228.
57. Zeng J., Davies M.J. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem. Res. Toxicol. 2005, 18:1232-1241.